Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Split-dose sodium picosulfate/magnesium citrate versus polyethylene glycol for outpatient colonoscopy preparation
IRCT20250526065902N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial in colorectal neoplasm, colonic polyp and colon adenoma comparing Split-dose SPMC with PEG (2 arms). Primary endpoint: Efficacy of bowel preparation. Started Jul 2025; status: completed.
02
Drugs
sodium picosulfate + magnesium oxide + citric acidmacrogol
03
Conditions
colorectal neoplasmcolonic polypcolon adenoma
Beyond the preview
Go deeper on IRCT20250526065902N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250526065902N1.